Innovus Pharma Announces the Filing of the Product Licenses for Zestra, Zestra Glide, EjectDelay and Sensum+ with the Indian FDA (Directorate General of Health Services)
Innovus Pharmaceuticals, Inc. ("Innovus Pharma") (OTCMKTS:INNV), an emerging commercial stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men and women's health and respiratory diseases, today announced today that its partner Khandelwal Laboratories filed the product licenses for Zestra®, Zestra Glide®, EjectDelay® and Sensum+® with the Indian FDA, The Drugs Controller General (India) and the Directorate General of Health Services to commercialize the products in India.
View full press release